Evidence map›Paper›PMID 32931017›Full record

ArticleImmunology2021

Tolerance induction in memory CD4 T cells is partial and reversible.

Joshua I Gray, Shaima Al-Khabouri, Fraser Morton, Eric T Clambey, Laurent Gapin, Jennifer L Matsuda, John W Kappler, Philippa Marrack, Paul Garside, Thomas D Otto and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Joshua I GrayInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
Shaima Al-KhabouriInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
Fraser MortonInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
Eric T ClambeyDepartment of Anesthesiology, University of Colorado Denver, Aurora, Colorado, USA.
Laurent GapinNational Jewish Health, Denver, Colorado, USA.
Jennifer L MatsudaNational Jewish Health, Denver, Colorado, USA.
John W KapplerNational Jewish Health, Denver, Colorado, USA.
Philippa MarrackNational Jewish Health, Denver, Colorado, USA.
Paul GarsideInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
Thomas D OttoInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
Megan K L MacLeodInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.ORCID 0000-0003-1843-8580
University of Glasgow · GBNational Jewish Health · USUniversity of Colorado Denver · US

Funding

CHARACTERISTICS OF T CELL RECEPTORSR01AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1985 to 2022
$7.3M
Arthritis Research UK 19905Howard Hughes Medical InstituteMedical Research Council MR/JR50032X/1NIAID NIH HHS R01 AI018785
6 · The paper itself

Abstract

Memory T cells respond rapidly in part because they are less reliant on a heightened levels of costimulatory molecules. This enables rapid control of secondary infecting pathogens but presents challenges to efforts to control or silence memory CD4 T cells, for example in antigen-specific tolerance strategies for autoimmunity. We have examined the transcriptional and functional consequences of reactivating memory CD4 T cells in the absence of an adjuvant. We find that memory CD4 T cells generated by infection or immunisation survive secondary activation with antigen delivered without adjuvant, regardless of their location in secondary lymphoid organs or peripheral tissues. These cells were, however, functionally altered following a tertiary immunisation with antigen and adjuvant, proliferating poorly but maintaining their ability to produce inflammatory cytokines. Transcriptional and cell cycle analysis of these memory CD4 T cells suggests they are unable to commit fully to cell division potentially because of low expression of DNA repair enzymes. In contrast, these memory CD4 T cells could proliferate following tertiary reactivation by viral re-infection. These data indicate that antigen-specific tolerogenic strategies must examine multiple parameters of Tcell function, and provide insight into the molecular mechanisms that may lead to deletional tolerance of memory CD4 T cells.

Indexed as

AnimalsAntigensAutoimmunityCD4-Positive T-LymphocytesCell CycleCell ProliferationCytokinesDNA RepairFemaleImmune ToleranceImmunologic MemoryInflammationLymphocyte ActivationMiceMice, Inbred C57BLTranscription, GeneticAntigensCytokinesmemory CD4 T cellsmitotic catastropheproliferationtolerance

Identifiers

PMID32931017
PMCPMC7730012
OpenAlexW3087694025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.